Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies
Top Cited Papers
- 29 June 2021
- journal article
- research article
- Published by Elsevier BV in The Lancet Rheumatology
- Vol. 3 (10), e715-e723
- https://doi.org/10.1016/s2665-9913(21)00105-3
Abstract
No abstract availableKeywords
Funding Information
- Janssen Research and Development LLC
This publication has 28 references indexed in Scilit:
- Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic ArthritisArthritis & Rheumatology, 2016
- Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA scoreAnnals Of The Rheumatic Diseases, 2015
- What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis?Current Opinion in Rheumatology, 2015
- The IL-23/IL-17 axis in psoriatic arthritisAutoimmunity Reviews, 2014
- Psoriatic Arthritis: a Critical ReviewClinical Reviews in Allergy & Immunology, 2012
- Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scoresAnnals Of The Rheumatic Diseases, 2010
- Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?Annals Of The Rheumatic Diseases, 2010
- Nomenclature for factors of the HLA system, 2010Tissue Antigens, 2010
- Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitisAnnals Of The Rheumatic Diseases, 2008
- Psoriatic spondyloarthropathy: A comparative study between HLA-B27 positive and HLA-B27 negative diseaseSeminars in Arthritis and Rheumatism, 2002